FDA Sends Warning Letters To Two Clinical Investigators

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA Sends Warning Letters to Two Clinical Investigators

J.W. Schomisch

March 21, 2025 at 08:39 AM EST

Two clinical investigators received FDA Warning Letters in March. A March 25 Warning Letter to Americo Padilla, M.D. alleged the clinical investigator in Miami Gardens, Fla., failed to obtain parental permission to enroll two minor subjects in a clinical trial. One of the subjects was enrolled in a trial on Oc. 10, 2022, completed a 28-day screening phase and was randomized ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA Sends Warning Letters to Two Clinical Investigators

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT